Cargando…
Phenothiazines to Treat Alzheimer’s Disease
Current treatments of Alzheimer’s Disease (AD) are largely ineffective and do not address underlying pathophysiological processes. The model organism C. elegans has been successfully used to discover compounds to treat human diseases, some now in clinical trials. To develop novel drugs and explore p...
Autores principales: | Litke, Rachel, Huang, Bik Tzu, Gonzalez, Damian, Rampanana, Martine, Grimaldi, Nicholas, Mobbs, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680962/ http://dx.doi.org/10.1093/geroni/igab046.2417 |
Ejemplares similares
-
Photoinduced free radicals from chlorpromazine and related phenothiazines: relationship to phenothiazine-induced photosensitization.
por: Chignell, C F, et al.
Publicado: (1985) -
THERAPEUTIC COMPLIANCE OF PATIENTS ON PHENOTHIAZINES
por: Ponnudurai, R., et al.
Publicado: (1983) -
Mechanism of the Dehydrogenative Phenothiazination of Phenols
por: Goswami, Monalisa, et al.
Publicado: (2018) -
New Functionalized Phenoxazines and Phenothiazines
por: Plater, M. John, et al.
Publicado: (2023) -
Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease
por: Makhaeva, Galina F., et al.
Publicado: (2015)